The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Optimizing tarlatamab therapy for relapsed small cell lung cancer: Biomarker identification and addressing treatment delivery disparity.
 
Parth Desai
Research Funding - ASCO
 
Lisa Bailey
No Relationships to Disclose
 
Sukhmani Padda
Honoraria - CME Solutions; Curio Science; Janssen; Jazz Pharmaceuticals; MECC Global Meetings; Medical Oncology Association of Southern California; Medical Oncology Association of Southern California; MJH Healthcare Holdings, LLC; Nanobiotix; OncLive/MJH Life Sciences; Physicans' Education Resource; The New England Journal of Medicine
Consulting or Advisory Role - Amgen; Amgen; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Blueprint Medicines; BMS GmbH & Co. KG; G1 Therapeutics; Genentech; Genzyme; Janssen Oncology; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Mirati Therapeutics; Mirati Therapeutics; RayzeBio; Regeneron; Regeneron; Sanofi; Summit Therapeutics; Takeda; Takeda
Research Funding - Amgen (Inst); BioAtla (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Regeneron
Other Relationship - NIH/NCI; OncLive/MJH Life Sciences
 
Roxana Taveira
No Relationships to Disclose
 
Rosemary Nagy
No Relationships to Disclose
 
Melissa Hutchison
No Relationships to Disclose
 
Joseph Bodor
Honoraria - Association of Community Cancer Centers (ACCC); MJH Life Sciences
Consulting or Advisory Role - Bayer; Daiichi Sankyo/Astra Zeneca; National Association of Continuing Education (NACE)
Research Funding - Genentech/Roche (Inst)
 
Maria Piddoubny
No Relationships to Disclose
 
Dana Wynne
No Relationships to Disclose
 
Julia Judd
No Relationships to Disclose
 
Hossein Borghaei
Stock and Other Ownership Interests - Nucleai; Rgenix; Sonnet
Honoraria - Amgen; Axiom Biotechnologies; Bristol-Myers Squibb; Celgene; Daiichi Sankyo/UCB Japan; Pfizer; Regeneron
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Bayer; Beigene; BerGenBio; BioNTech; Boehringer Ingelheim; Bristol-Myers Squibb; EMD Serono; Genentech; Genmab; Grid Therapeutics; Guardant Health; IO Biotech; ITeos Therapeutics; Janssen Oncology; Jazz Pharmaceuticals; Lilly; Merck; Mirati Therapeutics; natera; Novartis; oncocyte; Pfizer; PharmaMar; Puma Biotechnology; RAPT Therapeutics; Regeneron; Rgenix; Sonnet; Takeda
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Clovis Oncology; EMD Serono; Genentech; Lilly; Merck; Mirati Therapeutics; Novartis; Regeneron
Other Relationship - Incyte; Novartis; SpringWorks Therapeutics; Takeda; University of Pennsylvania